Exhibit 10.3 CONSULTING AGREEMENT This Consulting Agreement ("Agreement") is being entered into as of this 12th day of July, 2005, between APPLIED DNA SCIENCES, INC., a Nevada corporation (the "Company"), with offices at 9229 West Sunset Bvd, Suite...Consulting Agreement • July 21st, 2005 • Applied Dna Sciences Inc • Biological products, (no disgnostic substances) • California
EXHIBIT 10.1 APPLIED DNA SCIENCES, INC. Applied DNA Sciences, Inc., a Nevada corporation (the "Company"), hereby certifies that, for value received, _________________________ (the "Warrant Holder," which term includes its successors and registered...Warrant Agreement • September 7th, 2006 • Applied Dna Sciences Inc • Biological products, (no disgnostic substances) • New York
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 1st, 2022 • Applied Dna Sciences Inc • Services-miscellaneous business services • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of ________, 2022, between Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 3rd, 2016 • Applied Dna Sciences Inc • Services-miscellaneous business services
This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser (the “Purchase Agreement”).
April 8, 2005 Mr. Peter Brocklesby President Applied DNA Sciences, Inc. 9229 W. Sunset Boulevard, Suite 830 Los Angeles, CA 90069 Termination Agreement Dear Mr. Brocklesby: 1. Termination. (a) This letter (this "Letter Agreement") confirms our mutual...Termination Agreement • April 20th, 2005 • Applied Dna Sciences Inc • Biological products, (no disgnostic substances) • New York
RECITALSIndemnification Agreement • February 15th, 2005 • Applied Dna Sciences Inc • Biological products, (no disgnostic substances) • Delaware
FORM OF COMMON STOCK PURCHASE WARRANT APPLIED DNA SCIENCES, INC.Security Agreement • February 1st, 2024 • Applied Dna Sciences Inc • Services-testing laboratories • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Approval Effective Date (as defined in the Purchase Agreement) (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the fifth anniversary of the Approval Effective Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). For purposes hereof, “Shareholder Approval” means such approval, if required, by the applicable rules and regulations of the Nasdaq Stock
EXHIBIT 10.3 APPLIED DNA SCIENCES, INC. Applied DNA Sciences, Inc., a Nevada corporation (the "Company"), hereby certifies that, for value received, _________________________ (the "Warrant Holder," which term includes its successors and registered...Warrant Agreement • May 5th, 2006 • Applied Dna Sciences Inc • Biological products, (no disgnostic substances) • New York
EXHIBIT 10.1 SUBSCRIPTION AGREEMENT Applied DNA Sciences, Inc. 25 Health Sciences Drive, Suite 113 Stony Brook, New York 11790 Gentlemen and Ladies: The undersigned (the "Subscriber") hereby subscribes for ________ units, at a price of $50,000 per...Subscription Agreement • May 5th, 2006 • Applied Dna Sciences Inc • Biological products, (no disgnostic substances) • New York
RECITALSStock Purchase Agreement • February 2nd, 2005 • Applied Dna Sciences Inc • Services-computer processing & data preparation • Nevada
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 23rd, 2022 • Applied Dna Sciences Inc • Services-miscellaneous business services • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of February 21, 2022, between Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
EXHIBIT 10.4 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this "Agreement"), is made as of May ___, 2006, by and among Applied DNA Sciences, Inc., a Nevada corporation (the "Company"), and each of the undersigned (individually,...Registration Rights Agreement • May 5th, 2006 • Applied Dna Sciences Inc • Biological products, (no disgnostic substances) • New York
SHARE EXCHANGE AGREEMENT THIS AGREEMENT is made this 4th day of May, 1999 by and among DCC Acquisition Corp., a Nevada corporation, hereinafter called "DCC", New Cinema Partners Inc., an Ontario, Canada corporation, hereinafter called "NCPI:, and The...Share Exchange Agreement • June 11th, 1999 • DCC Acquisition Corp • Services-computer processing & data preparation • Nevada
Exhibit 4.3 APPLIED DNA SCIENCES, INC. WARRANT AGREEMENT, dated _________, 2005 (the "Agreement"), by and between Applied DNA Sciences, Inc., a Nevada corporation (the "Company"), and __________________ the holder of one (1) unit of the Company sold...Warrant Agreement • January 28th, 2005 • Applied Dna Sciences Inc • Services-computer processing & data preparation • New York
SERIES B COMMON STOCK PURCHASE WARRANT APPLIED DNA SCIENCES, INC.Warrant Agreement • May 29th, 2024 • Applied Dna Sciences Inc • Services-testing laboratories • New York
THIS SERIES B COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [___________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Stockholder Approval Date (as defined below) (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the one (1) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), up to [______] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
APPLIED DNA SCIENCES, INC. WARRANT AGREEMENT, dated March __, 2006 (the "Agreement"), by and between Applied DNA Sciences, Inc., a Nevada corporation (the "Company"), and __________________ (individually the "Warrant Holder" and collectively with...Warrant Agreement • March 14th, 2006 • Applied Dna Sciences Inc • Biological products, (no disgnostic substances) • New York
PRE-FUNDED COMMON STOCK PURCHASE WARRANT APPLIED DNA SCIENCES, INC.Pre-Funded Common Stock Purchase Warrant • October 31st, 2024 • Applied Dna Sciences Inc • Services-testing laboratories • New York
THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [___________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), up to [______] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
WHEREAS:Merger Agreement • February 8th, 1999 • Datalink Capital Corp/Tx/ • Services-computer processing & data preparation
SERIES C COMMON STOCK PURCHASE WARRANT APPLIED DNA SCIENCES, INC.Securities Agreement • October 31st, 2024 • Applied Dna Sciences Inc • Services-testing laboratories • New York
THIS SERIES C COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [___________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Stockholder Approval Date (as defined below) (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), up to [______] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 22nd, 2013 • Applied Dna Sciences Inc • Industrial organic chemicals • New York
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of July 19, 2013, is by and among Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), and the undersigned buyer (the “Buyer”).
PLACEMENT AGENCY AGREEMENT January 31, 2024Placement Agency Agreement • February 1st, 2024 • Applied Dna Sciences Inc • Services-testing laboratories • New York
Engagement AgreementEngagement Agreement • February 15th, 2005 • Applied Dna Sciences Inc • Biological products, (no disgnostic substances) • New York
RECITALSIndemnification & Liability • February 15th, 2005 • Applied Dna Sciences Inc • Biological products, (no disgnostic substances) • Nevada
October 20, 2005 Biowell Technology Inc. 18F, No. 959 Chung-Cheng Rd. Chung-Ho City Taipei County Taiwan 235 ROC Re: Amended License Agreement ------------------------- Dr. Jun-Jei Sheu: As referenced in the Exclusive Licensing Agreement, dated as of...License Agreement • October 28th, 2005 • Applied Dna Sciences Inc • Biological products, (no disgnostic substances)
Exhibit 10.1 AGREEMENT OF LEASE LONG ISLAND HIGH TECHNOLOGY INCUBATOR, INC. Applied DNA November 2005 thru October 2006 AGREEMENT OF LEASE This Lease dated this First day November 2005 is by and between LONG ISLAND HIGH TECHNOLOGY INCUBATOR, INC., a...Lease Agreement • October 27th, 2005 • Applied Dna Sciences Inc • Biological products, (no disgnostic substances)
COMMON STOCK PURCHASE WARRANT applied dna sciences, inc.Security Agreement • February 23rd, 2022 • Applied Dna Sciences Inc • Services-miscellaneous business services
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after August __, 2022 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ________1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from DNA Applied Sciences, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 20th, 2017 • Applied Dna Sciences Inc • Services-miscellaneous business services • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of December 20, 2017, among Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
RECITALSIndemnity Agreement • February 15th, 2005 • Applied Dna Sciences Inc • Biological products, (no disgnostic substances) • Nevada
PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT APPLIED DNA SCIENCES, INC.Placement Agent Common Stock Purchase Warrant • May 29th, 2024 • Applied Dna Sciences Inc • Services-testing laboratories • New York
THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [___________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on [_____], 20291 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), up to [______] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to the certain Placement Agency Agreement, dated as of [_____], 2024, by and between the Company, Craig-Hallum Capital Group LLC and Laidlaw Company (UK) Ltd.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 31st, 2024 • Applied Dna Sciences Inc • Services-testing laboratories • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of October 30, 2024, between Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
Exhibit 10.2 INDEPENDENT CONTRACTOR AGREEMENT THIS INDEPENDENT CONTRACTOR AGREEMENT ("Agreement") is entered into by and between APPLIED DNA SCIENCES, INC. a Nevada corporation with its offices located at 9229 Sunset Blvd., Suite 830, West Hollywood,...Independent Contractor Agreement • October 27th, 2005 • Applied Dna Sciences Inc • Biological products, (no disgnostic substances) • California
Exhibit 4.5 SECURITY AGREEMENT SECURITY AGREEMENT dated January 28, 2005, between Vertical Capital Partners, Inc., a Delaware corporation, as agent (the "Agent") for the benefit of the individuals or entities listed on Schedule A hereto ("Creditor"),...Security Agreement • January 28th, 2005 • Applied Dna Sciences Inc • Services-computer processing & data preparation • New York
RECITALS --------Stock Purchase Agreement • July 21st, 2005 • Applied Dna Sciences Inc • Biological products, (no disgnostic substances)
PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT APPLIED DNA SCIENCES, INC.Placement Agent Agreement • October 31st, 2024 • Applied Dna Sciences Inc • Services-testing laboratories • New York
THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [___________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Stockholder Approval Date (as defined below) (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on October 30, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), up to [______] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to the certain engagement agreement, dated August 23, 2024, by and between the Company and Craig-Hallum Capital Group LLC.
APPLIED DNA SCIENCES, INC. Up to $6,397,939 of Common Stock EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • November 7th, 2023 • Applied Dna Sciences Inc • Services-testing laboratories • New York
Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), proposes to issue and sell through Maxim Group LLC, as exclusive sales agent (the “Agent”), shares of common stock, par value $0.001 per share, of the Company (the “Common Stock”), having an aggregate offering price of up to $6,397,939 (the Common Stock subject to this Equity Distribution Agreement (this “Agreement”) being referred to herein as the “Shares”) on terms set forth herein and subject to the limitations set forth in Section 2 hereof. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
